Evidence map›Paper›PMID 41534005›Full record

ArticleJCO clinical cancer informatics2026

Knowledge Representation of a Multicenter Adolescent and Young Adult Cancer Infrastructure: Development of the STRONG AYA Knowledge Graph.

Joshi Hogenboom, Varsha Gouthamchand, Charlotte Cairns, Silvie H M Janssen, Kirsty Way, Andre L A J Dekker, Winette T A van der Graaf, Anne-Sophie Darlington, Olga Husson, Leonard Y L Wee and 2 more

Abstract readMulticenter Study
In one paragraph

Article in JCO clinical cancer informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joshi HogenboomDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.ORCID 0000-0003-1278-3295
Varsha GouthamchandDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.ORCID 0000-0002-4756-2866
Charlotte CairnsSchool of Health Sciences, University of Southampton, Southampton, United Kingdom.ORCID 0000-0003-0968-9556
Silvie H M JanssenDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0003-1406-1739
Kirsty WaySchool of Health Sciences, University of Southampton, Southampton, United Kingdom.ORCID 0009-0001-2287-1398
Andre L A J DekkerDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.ORCID 0000-0002-0422-7996
Winette T A van der GraafDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0001-7549-3338
Anne-Sophie DarlingtonSchool of Health Sciences, University of Southampton, Southampton, United Kingdom.ORCID 0000-0003-4387-7278
Olga HussonDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-1387-8686
Leonard Y L WeeDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.ORCID 0000-0003-1612-9055
Johan van SoestDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.ORCID 0000-0003-2548-0330
Aiara Lobo GomesDepartment of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.ORCID 0000-0003-4670-6036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRare diseases are difficult to fully capture, and regularly call for large, geographically dispersed initiatives. Such initiatives are often met with data harmonization challenges. These challenges render data incompatible and impede successful realization. The STRONG AYA project is such an initiative, specifically focusing on adolescent and young adult (AYAs) with cancer. STRONG AYA is setting up a federated data infrastructure containing data of varying format. Here, we elaborate on how we used health care-agnostic semantic web technologies to overcome such challenges.

methodsWe structured the STRONG AYA case-mix and core outcome measures concepts and their properties as knowledge graphs. Having identified the corresponding standard terminologies, we developed a semantic map on the basis of the knowledge graphs and the here introduced annotation helper plugin for

resultsThe knowledge graphs provided a comprehensive overview of the large number of STRONG AYA concepts. The semantic terminology mapping and annotation helper allowed us to query data with incomprehensible terminologies, without changing them. Both the knowledge graphs and semantic map were made available on a Hugo webpage for increased transparency and understanding.

conclusionThe use of semantic web technologies, such as RDF and knowledge graphs, is a viable solution to overcome challenges regarding data interoperability and reusability for a federated AYA cancer data infrastructure without being bound to rigid standardized schemas. The linkage of semantically meaningful concepts to otherwise incomprehensible data elements demonstrates how by using these domain-agnostic technologies we made nonstandardized health care data interoperable.

Indexed as

NeoplasmsAdolescentAdultHumansSemanticsSemantic WebYoung Adult

Identifiers

PMID41534005
PMCPMC12834280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.